Circulation Journal 2012-01-01

Intensive glucose lowering in cardiovascular risk management - unsolved questions - .

Michio Shimabukuro, Hiroaki Masuzaki, Masataka Sata

Index: Circ. J. 76(3) , 593-5, (2012)

Full Text: HTML

Abstract


Related Compounds

Related Articles:

Formulation and in vitro evaluation of nateglinide microspheres using HPMC and carbopol-940 polymers by ionic gelation method.

2013-11-01

[Pak. J. Pharm. Sci. 26(6) , 1229-35, (2013)]

From evidence assessments to coverage decisions?: the case example of glinides in Germany.

2012-01-01

[Health Policy 104(1) , 27-31, (2012)]

Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.

2005-10-01

[Int. J. Clin. Pract. 59(10) , 1218-28, (2005)]

Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial.

2012-02-01

[Diabetes Obes. Metab. 14(2) , 187-9, (2012)]

Nateglinide (Starlix): update on a new antidiabetic agent.

2003-01-01

[Int. J. Clin. Pract. 57(6) , 535-41, (2003)]

More Articles...